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Background: Rapid diagnostic tests (RDTs) have revolutionized the diagnosis of malaria. Among the various factors
affecting RDTs sensitivity is genetic variation of the antigen used. The genetic variation in PfHRP2 and PfHRP3
proteins was studied among the Indian Plasmodium falciparum isolates.
Methods: One hundred and forty isolates of P. falciparum were collected from six geographical regions of India.
Target genes encoding PfHRP2 and PfHRP3 antigens were sequenced to study genetic polymorphism. Minimum
detection limit giving a positive rapid diagnostic test was also determined.
Results: Extensive variations were observed in amino acid repeat types of PfHRP2 and PfHRP3. PfHRP2 exhibited
more polymorphism than PfHRP3. Significant relation was observed between type 2 and type 7 repeats and RDT
detection rate as higher number of these repeats showed better sensitivity with RDTs.
Conclusion: The results provide insights into the genetic diversity of Pfhrp2 and Pfhrp3 genes among Indian P.
falciparum population and its relation to RDT sensitivity.
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Malaria is an important public health problem in India
with 1.5 million confirmed cases reported annually by
the National Vector Borne Disease Control Programme
(NVBDCP) [1]. Early diagnosis and effective treatment is
one of the important strategies for malaria control and
malaria RDTs form an important component of diagno-
sis. Detection of malaria parasites by microscopic exam-
ination of blood smears remains the gold standard but
may not be easily available especially in remote areas.
The development of alternative diagnostic method like
RDTs has made it possible to provide rapid and accurate
detection of malaria parasites in remote areas where* Correspondence: anvikar@rediffmail.com
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reproduction in any medium, provided the ormicroscopy facility is not available. RDTs are lateral
immunochromatographic tests, which detect specific
antigens of the malaria parasite, such as the Plasmodium
falciparum-specific histidine rich protein 2 (PfHRP2).
Other RDTs use lactate dehydrogenase and aldolase
and can also detect non-falciparum infections. Most of
the RDTs show excellent sensitivity and specificity for
P. falciparum at a parasitaemia greater than 500 para-
sites per microlitre (parasites/μl) but at lower parasit-
aemia, the sensitivity is variable [2]. The majority of
P. falciparum-specific RDTs detect P. falciparum histi-
dine rich protein 2 (PfHRP2) but due to structural
homology of PfHRP2 with PfHRP3, the latter also con-
tributes to diagnosis of malaria [3].
Several factors affect the performance of malaria
RDTs, which include test factors and parasite factors.
But in addition to these, there is one more importantLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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gen being detected by the RDTs. This includes presence
or absence and variations in the number of the target
epitopes present in a particular parasite strain. Genetic
diversity may be an important factor for these antigen-
based RDTs and it has been reported that the PfHRP2
antigen varies in size between different parasite strains
[4,5]. The antigen consists of a number of alanine and
histidine rich amino acid repeats which also affects the
detection limit of RDTs [6, 7,]. Different allelic forms of
these diagnostic genes have been reported in several la-
boratories [6-8]. However, no systematic examination of
diversity in these genes has been carried out in Indian iso-
lates, nor has any relationship between genetic diversity of
diagnostic antigen and RDT detection sensitivity been
examined, while variable sensitivity has been observed.
The present study was aimed to investigate the genetic
diversity of Pfhrp2 and Pfhrp3 genes in P. falciparum iso-
lates from different epidemiological strata for malaria in




Total 140 P. falciparum isolates were collected from six
states (Chhattisgarh, West Bengal, Madhya Pradesh, Gujarat,
Orissa and Karnataka) of India from December 2009 to
September 2011 (Figure 1). These samples also included
panels prepared for quality assurance of RDTs and culture
adapted samples from the Malaria Parasite Bank of National
Institute of Malaria Research (NIMR). The study was
approved by institutional ethics committee of NIMR New
Delhi, India. Written Informed consent was obtained from
the participants. Consent was obtained from parents in case
of minor. Blood samples were collected by finger prick and
used for RDT testing. They were also stored as dried blood
spots on filter papers. All the diagnosed cases of malaria
were treated as per the national drug policy.
RDT detection rate
Minimum parasitaemia that could be detected by RDTs
was analyzed in 62 samples, which included 51 field iso-
lates, nine quality assurance panels and two lab adapted
culture lines. Parasite densities were determined against
200 white blood cells as per the WHO recommenda-
tions. Parasite blood suspensions were prepared by serial
dilution with healthy human O group blood, 10, 000 p/μl,
2000 p/μl, 1000 p/μl, 500 p/μl, 250 p/μl, 125 p/μl and 62
parasites/μl. Minimum parasitaemia giving positive result
was analysed with HRP2 based RDTs (Para check, Orchid
Biomedical System, India). The RDT detection sensitivity
was categorized as sensitive (minimum detection limit≤200
parasites/μl) and non sensitive (minimum detection
limit ≥ 200 parasites/μl).Genomic DNA isolation and diagnostic PCR
Genomic DNA was isolated from dried filter spot by
QIAamp DNA mini kit (QIAGEN, California, USA)
according to the manufacturer’s instructions. The identi-
fication of P. falciparum was confirmed by polymerase
chain reaction (PCR) using species specific primers, as
previously described by Snounou et al. at modified cyc-
ling conditions [9].
Detection of Pfhrp2 and Pfhrp3 genes by PCR
Gene specific primers were used to amplify Pfhrp2 and
Pfhrp3 genes. Two microlitres of isolated DNA was used
as a template in 25 μl PCR reaction mixtures that con-
tained 2.5 mM MgCl2, 10 pM of each primer and 0.2U
of Amplitaq gold DNA polymerase. The DNA was ini-
tially denatured at 95°C for 5 min followed by 40 cycles
of denaturation at 95°C for 30 sec, annealing at 57°C for
40 sec and extension at 72°C for 90 sec. The final exten-
sion was performed at 72°C for 10 min. Reaction cycling
conditions were same for both the target genes except
annealing temperature (55°C for Pfhrp3 gene). The pri-
mer sequences as described earlier [7] were used to amp-
lify the exon 2 of Pfhrp2 and Pfhrp3 genes (Pfhrp2 F- 5’-
TGTGTAGCAAAAATGCAAAAGG-3’ Pfhrp2 R- 5’- TTA
ATGGCGTAGGCAATGTG-3’, Pfhrp3: F- 5’-AAATAAGA
GATTATTACACGAAAG-3’, Pfhrp3: R- 5’- TGGTGTAAG
TGATGCGTAGT-3’). Ten microlitres of PCR products
was separated by electrophoresis on a 1.5% agarose gel.
The fragment size of PCR products was determined by
comparison with molecular weight marker (100 bp)
using molecular weight analysis of gel documentation
system.
Direct sequencing of PCR products and translation
All PCR products were purified by use of spin columns
(QIAGEN) according to manufacturer’s instructions and
were used in a standard dye-terminator DNA sequen-
cing reaction (ABI). Nucleotide sequences were trans-
lated to corresponding amino acids and each type of
amino acid repeat sequences were identified and given
numeric codes from type 1 to type 18 as described in
previous study [6].
Data analysis
Sequences of poor quality were not analysed. Amino-acid
sequences of the corresponding proteins were deduced
from the nucleotide sequences. The predictive binary logis-
tic regression analysis model developed by Baker et al. was
used to evaluate isolates as sensitive (≤ 200 parasites/μl)
and non sensitive (≥ 200 parasites/μl) by PfHRP2 based
RDT. Bio Edit Sequence Alignment Editor Software [10]
was used to align the nucleotides and deduce amino acid
sequences of different isolates with the reference sequences
of P. falciparum strains, 7 G8 for Pfhrp2 (Accession M13986)
Figure 1 Map of India showing geographical distribution of samples (140 P. falciparum isolates). 1. Chhattisgarh (n = 40), 2. Gujarat
(n = 20), 3. Karnataka (n = 10), 4. Madhya Pradesh (n = 20), 5. Orissa (n = 30), 6. West Bengal (n = 20)
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spectively. Differences in mean number of amino acid
repeats between six different regions were assessed for
each type of repeats by Kruskall-Wallis test (H- test)
using SPSS software. P value < 0.05 was interpreted as
indicating statistically significant differences.
Results
Genetic variations in Pfhrp2 and Pfhrp3
Of the 140 P. falciparum isolates, 108 samples showed
PCR amplification for Pfhrp2 fragments. These PCR
amplified fragments showed extensive variations in size
and ranged from 472 to 1,000 bp, while coding proteins
ranged from 157 to 333 amino acids. Eight of 14 previ-
ously identified amino acids were detected [6] along with
five unique repeat sequences. A total of 13 repeat type
sequences of Pfhrp2 were identified in Indian isolates.
All Pfhrp2 sequences showed a similar structure, starting
with type 1 repeat (AHHAHHVAD) and ended with type
12 (AHHAA) repeat sequences except in Gujarat isolates.
The central part of Pfhrp2 sequences contained the com-
bination of types 2, 4,5,6,7 and 8 repeat sequences. Among
all 13 repeat sequences, type 2 (AHHAHHAAD) & type 7(AHHAAD) were more frequent. Some repeats (type 1, 2,
3, 6, 7 and 11) were common in all, whereas others (type
9, 10, 12 and type 13) were not observed or were found
only in few isolates. Two unique sequences type 9
(AHHAPH) and type 10 (AHHAPD) were found only in
isolates from Chhattisgarh. Isolates from West Bengal
showed higher frequency of type 2 repeats (46.87%) than
isolates from other geographical regions of India and low
frequency of type 3 repeats (3.12%) than other regions.
Variations in fragment size and amino acid repeat
types were more extensive in Pfhrp2 as compared to
Pfhrp3. Some of the repeat types 1,2,3,6,7,11 were
observed in all isolates. Number of each repeat and total
number of repeats within Pfhrp2 varied between differ-
ent isolates of the country (Table 1). When it was com-
pared between different geographical regions, differences
were observed for six repeat types. Isolates of Madhya
Pradesh had significantly less type 2 repeats (mean 6.3)
than isolates from Karnataka (mean 9.8) and West Bengal
(mean 9.8) (p = 0.85). For type 6 repeats, isolates of
Madhya Pradesh (mean 0.6) had significantly fewer
repeats than isolates of Orissa (mean 2.5) (p = 0.001). For
type 7 repeats, isolates from Chhattisgarh (mean 0.7) and








Antigens observed No. of individual repeats in different regions of India Total
RepeatsPfhrp2 Pfhrp3 Chhattisgarh West Bengal M.P. Gujarat Orissa Karnataka
1 AHHAHHVAD + - 1-2 1-3 1-4 1-2 1-3 1-2 1-4
2 AHHAHHAAD + - 2-14 2-15 2-9 3-11 2-11 2-11 2-14
3 AHHAHHAAY + - 0-1 0-1 0-1 0-1 1-2 0-1 0-2
4 AHH + - 1-3 0-2 0 0-2 0-2 0-2 0-3
AHH - + 0 0-1 0 0-2 0-2 0 0-2
5 AHHAHHASD + - 0 0-2 0-1 0-1 0-1 0-2 0-2
6 AHHATD + - 0-4 0-2 0-1 0-1 0-5 0-2 0-2
7 AHHAAD + - 0-1 0-2 1-2 1-6 1-5 0-3 0-4
AHHAAD - + 0-1 0-1 1-2 0-1 1-2 0-1 0-2
8 AHHAAY + - 0 1-2 0-1 0-1 0-1 0-1 0-2
9 AHHAPH + - 0-1 0 0 0 0 0 0-1
10 AHHAPD + - 0-1 0 0 0 0 0 0-1
11 AHVDD + - 0-1 0-1 0-1 0-1 0-1 0-1 0-1
12 AHHAA + - 0-2 0-1 0-2 0 0-3 0-2 0-1
13 AHHEAA + - 0-1 0-1 0-1 0 0 0 0-1
14 AHHAAN - + 2-15 2-12 2-9 3-11 2-14 3-12 2-15
15 AHHDGAHHDD - + 1-2 1-2 1-2 1-2 1-2 1-2 1-2
16 AHHDGAHHDG - + 0-2 1-2 1-2 0-2 1-2 1-2 0-2
17 AHHDG - + 0-2 0 0 0 0 0 0-2
18 AHHN - + 0-2 0 0 0 0 0 0-2
Note: Bold letters - Pfhrp2 sequences, Italic – Pfhrp3 sequences.
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Orissa (mean 3.9) (p= 0.001). Type 4 repeats were not
found in isolates from Madhya Pradesh, but present in all
other regions where as type 5 and type 8 were not found
in Chhattisgarh isolates but interestingly they had type
9 (mean 0.3) and type 10 (mean 0.2) which were absent
in isolates of other geographical regions. Type 12 repeat
sequences were not observed in Gujarat isolates but
type 13 was not found in isolates of Gujarat, Orissa and
Karnataka.
Of the 140 P. falciparum isolates, 103 showed PCR
amplification for Pfhrp3. The size of Pfhrp3 amplified
fragments ranged from 477 bp to 832 bp which encoded
proteins of 159 to 277 amino acids. Five of the eight pre-
viously reported repeat types were identified (Table 1).
All Pfhrp3 fragments showed a similar structure i.e.
starting with type 4 repeats (AHH) and ending with the
combination of type 15 and type 16. Frequency of type
14 repeat (AHHAAN) sequences was higher in all the
isolates (mean, 8.95) (p = 0.88) followed by type 15 and
type 16 whereas type 17 (AHHDG) (mean 1.3) and type
18 (AHHN) (mean 1.1) were found only in isolates of
Chhattisgarh. The difference in repeats number betweendifferent geographical regions was not statistically sig-
nificant (P > 0.05).
RDT detection rate
Minimum parasitaemia that could be detected by RDTs
was analysed in 62 samples. Extensive variations were
observed in the minimum parasite detection limit
(Table 2). The minimum level of parasitaemia that could
be detected by RDTs ranged from 62 p/μl to 500 p/μl
(Mean- 220.7 p/μl). About 75% of the isolates were pre-
dicted to be detected by RDTs at parasite density > 200 p/μl.
The relationship between type 2× type 7 amino acid repeats
of PfHRP2 and average minimum detection limit of RDTs
has been presented as Figure 2. It was observed that higher
number of these repeats was associated with better sensi-
tivity of HRP2 based RDTs. The same was confirmed by
Baker’s logistic regression analysis.
Discussion
Malaria diagnostic tests provide early and accurate diag-
nosis of malaria. This enables prompt treatment and its
control especially in remote inaccessible areas. Apart
from various other factors genetic polymorphism in
Table 2 Distribution of 62 selected P. falciparum isolates/lines from different regions of India and their minimum




No. of P. falciparum isolates
Chhattisgarh Madhya Pradesh Gujarat West Bengal Orissa Karnataka Malaria Parasite Bank Total
62 p/μl 4 0 0 0 0 3 0 7
125 p/μl 10 2 3 2 8 9 2 36
250 p/μl 3 1 1 1 1 2 0 9
500 p/μl 3 2 0 1 1 3 0 10
Total 20 5 4 4 10 17 2 62
(Individual detection limits are given as Additional file 1: Table S1).
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Pfhrp3, is also an important factor responsible for variable
sensitivity of malaria RDTs. These antigens consist of a
number of alanine- and histidine-rich amino acid repeats
[6-8] and vary in size between parasite strains and com-
parison of the PfHRP2 sequences from several parasite
strains has shown differences in the number of tri- and
hexapeptide repeat units and rare amino acid variants [6].
Effects of sequence variation in P. falciparum histidine-
rich protein 2 on binding of specific monoclonal anti-
bodies have been also reported [11]. However, the degree
of antigen variation has recently been shown to be limited
for pLDH and parasite aldolase [12,13].
Only six out of the 13 identified different amino acid
repeats were found to be present in all isolates. Rest of
the repeats were distributed randomly among isolates
from different geographical areas. Most of the RDTs for
falciparum malaria are based on P. falciparum-specific
histidine rich protein specific monoclonal antibody. If
RDTs recognizes epitopes present in repeat sequences that
are not universally present, it may lead to misdiagnosis of
malaria or variable performance of RDTs especially at lowFigure 2 Relationship between number of type 2× type 7 amino acid
among six different geographical regions of India.parasitaemia. Relation between the number of type 2 and
type 7 repeats and RDT detection rate was confirmed sta-
tistically. This suggests that the epitopes recognized by
PFHRP2-specific monoclonal antibody reside within or
near around type 2 and type 7 repeats. These two repeat
types were more common and frequent in all geographical
isolates of India. Similar results were also observed in
global isolates [6-8].
Number of these repeats varied from 2 to 15 in Pfhrp2
and 1 to 6 in Pfhrp3. The data of the present study sup-
ports the findings reported earlier. RDTs may fail to de-
tect the isolates with less number of types 2 and 7 repeat
sequences at lower parasite density i.e. ≤ 200 parasites/μl.
Another possible factor affecting the sensitivity of HRP2-
detecting RDTs is failure of the parasite to express the
antigen, due to deletion of genes or frame shift mutations,
or alterations in protein expression. However, parasite
lines lacking either or both Pfhrp2 or Pfhrp3 genes have
only been identified following laboratory adaptation to
in vitro culture [14] and in the progeny of a genetic cross
[15] now it has been characterized that a number of P.
falciparum isolates collected in Iquitos, Peru and brazilrepeats of PfHRP2 and average minimum detection limit of RDTs
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that were positive by microscopy but tested negative
with HRP2-detecting RDTs [16,17].
It has been reported that due to structural homology of
PfHRP3 with PfHRP2, it cross reacts with antibody coated
in RDTs for PfHRP2. Hence, PfHRP3 also contributes to
the diagnosis of falciparum malaria [3]. The results showed
that two types of amino acid repeat sequences i.e. type 4 &
type 7 were common in both Pfhrp2 and Pfhrp3 genes.
Five repeats were found only in Pfhrp3 gene (type 14, type
15, type 16, type 17 and type 18). This suggests that some
of the epitopes detected by monoclonal antibody of RDTs
were also found in PfHRP3 although PfHRP3 was less vari-
able than PfHRP2. Cross-reactivity between PfHRP2 and
PfHRP3 has also been reported for several PfHRP2-specific
monoclonal antibodies like 2 G12, MAB87 and ID6 [4].
The antibodies generated against PfHRP2 and PfHRP3 pre-
dominantly recognize the corresponding antigen, but
weakly recognize other antigens [18]. The cross reactivity
between these two antigen is also likely to modulate the
effect of genetic diversity of Pfhrp2 and Pfhrp3 on RDTs
performance. There is some published information on spe-
cific epitopes of antibodies used in RDTs [12]. Six mono-
clonal antibodies are also published that are directed
against PfHRP2 [19-22], but due to the limited supply of
monoclonal antibody, most of the PfHRP2-based RDTs use
similar or identical antibodies. Hence, the effect of genetic
variation in these diagnostic genes on performance of
RDTs is also applicable for most of the commercial
PfHRP2-based RDTs. The data predicts that ~ 25% para-
sites of India are not detectable at parasitaemia level < 200
parasites/μl. However, more comprehensive genetic vari-
ation analysis with larger sample size for each geographical
malaria endemic region of country is needed to support
this hypothesis. During this study, two cases of Pfhrp2/
Pfhrp3 gene deletion in P. falciparum field isolates from
Chhattisgarh have also been found and will be presented as
a separate report. Hence, there is need to investigate the
geographical extent of Indian P. falciparum isolates lacking
Pfhrp2 and/or Pfhrp3 genes. Besides this, comprehensive
analysis of other target antigens of malaria RDTs, such as
pLDH and aldolase among Indian isolates is also needed.
Conclusion
The study provides Indian data on variation and se-
quence information of Pfhrp2 and Pfhrp3 genes and its
effect on performance of RDTs. The results will provide
platform in designing more sensitive RDTs.
Nucleotide sequence accession numbers
The nucleotide sequences reported here have been depos-
ited in the GenBank database under accession numbers
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for P. falciparum hrp3 sequences.
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